Orbimed Advisors LLC Merck & Co., Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,316,000 shares of MRK stock, worth $131 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares

1,316,000

Previous 1,316,000 -0.0%

Holding current value

$131 Million

Previous $163 Million 8.27%

% of portfolio

3.52%

Previous 3.93%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $29.6 Million - $34.4 Million	261,000 Added 24.74%	1,316,000 $174 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $109 Million - $121 Million	1,055,000 New	1,055,000 $109 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $131 Million - $147 Million	-1,779,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $141 Million - $177 Million	-1,953,100 Reduced 52.33%	1,779,300 $136 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $73.9 Million - $87 Million	1,073,100 Added 40.35%	3,732,400 $288 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $5.04 Million - $5.59 Million	70,200 Added 2.71%	2,659,300 $218 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $40.2 Million - $55.8 Million	635,000 Added 32.5%	2,589,100 $199 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $46.9 Million - $51.1 Million	-616,000 Reduced 23.97%	1,954,100 $164 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $5.23 Million - $5.96 Million	75,100 Added 3.01%	2,570,100 $214 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $68.5 Million - $79.5 Million	-1,049,400 Reduced 29.61%	2,495,000 $191 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $65.5 Million - $77 Million	-1,135,600 Reduced 24.26%	3,544,400 $251 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $30.9 Million - $36.3 Million	-608,200 Reduced 11.5%	4,680,000 $284 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $84.7 Million - $98.5 Million	1,662,800 Added 45.87%	5,288,200 $288 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $96.1 Million - $115 Million	-1,861,600 Reduced 33.93%	3,625,400 $204 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $322 Million - $346 Million	5,487,000	5,487,000 $351 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Merck & Co., Inc. Transaction History